Article

Subretinal device improves visual function in RP patients

Author(s):

Fort Lauderdale, FL-Visual function improvement is still apparent and better than ex-pected more than 3 years following the first implantation of a subretinal Artificial Silicon Retina (ASR, Optobionics Corp.) micro-chip in patients experiencing vision loss from retinitis pigmentosa (RP). This degree of improvement could be due at least in part to a neurotrophic effect, said Alan Y. Chow, MD, co-developer of the ASR.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.